Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where uwa K is active.

Publication


Featured researches published by uwa K.


The American Journal of Chinese Medicine | 1991

Anticancer effects of a chinese Herbal medicine, Juzen-taiho-to, in combination with or without 5-fluorouracil derivative on DNA-synthesizing enzymes in 1,2-dimethylhydrazine induced colonic cancer in rats

Shinobu Sakamoto; Hideki Kudo; Kuwa K; Satoe Suzuki; Tomoyasu Kato; Tohru Kawasaki; Tohru Nakayama; Noriyuki Kasahara; Ryohei Okamoto

Juzen-taiho-to (JTT; [Shi-quan-da-bu-tang], a Japanese modified Chinese herbal prescription) in combination with an anticancer drug UFT (5-fluorouracil derivative) prevented the body weight loss and the induction of the colonic cancer in rats treated with a chemical carcinogen 1,2-dimethylhydrazine (DMH), and suppressed markedly the activity of thymidylate synthetase (TS) involved in the de novo pathway of pyrimidine synthesis in colonic cancer induced by DMH.


The American Journal of Chinese Medicine | 1993

Suppression of Spontaneous Development of Uterine Adenomyosis and Mammary Hyperplastic Alveolar Nodules by Chinese Herbal Medicines in Mice

Takao Mori; Shinobu Sakamoto; Manabu Matsuda; Kyokuwa M; Hideo Namiki; Kuwa K; Seiichiro Kawashima; Hiroshi Nagasawa

The effects of traditional Chinese herbal remedies, Shakuyaku-kanzo-to (SKT) and Hachimijiou-gan (HJG), on the spontaneous development of uterine adenomyosis and mammary hyperplastic alveolar nodules (HAN) were examined in an experimental animal model using SHN strain of mice. Female mice were provided with the chow containing 1% of SKT or HJG during 25-150 days of age. At 150 days of age, SKT treatment showed significantly lower incidence of adenomyosis, and HJG treatment resulted in a significantly lower incidence of HAN when compared to a control chow containing no medicines. Long-term exposure to these herbal medicines affected little serum prolactin (PRL) level, estrous cycle, food intake and body growth. Thus, the present mouse data suggest that the oral administration of these herbal medicines is a useful tool for the treatment of uterine adenomyosis or mammary disorder such as cystic mastitis.


Anti-Cancer Drugs | 1998

Additive effects of medroxyprogesterone acetate and 5-fluorouracil derivative on 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.

Shinobu Sakamoto; Yukichi Hara; Tadasu Mitamura; Shuji Sassa; Hideki Kudo; Satoe Suzuki; Kuwa K; Isao Okayasu; Hisashi Shinoda

Chronic oral administration of 1-(2-tetrahydrofuryl)-5-fluorouracil in combination with uracil suppressed thymidylate syntetase (TS) gene expression followed by reduction of TS activity in rat mammary tumors induced with 7,12-dimethylbenz[a]anthracene. Addition of medroxyprogesterone acetate (MPA) to the anticancer drug caused an additional decrease in TS and thymidine kinase activities in the tumor growth and restoration of bone loss. These results suggest that the simultaneous adminstration of MPA and anticancer drugs causes increased inhibition of mammary tumor growth and also diminishes the bone loss.


Steroids | 1993

Effects of Danazol on endometrial DNA synthesis in rats

Satoe Suzuki; Shinobu Sakamoto; Hideki Kudo; Shuji Sassa; Yoshie Sugiura; Kuwa K; Noriyuki Kasahara; Takao Mori; Hiroshi Nagasawa

The suppressive effects of Danazol, an isoxazol derivative of the synthetic steroid 17 alpha-ethinyltestosterone, on endometrial DNA synthesis were investigated in rats by immunohistochemistry with bromodeoxyuridine (BrdU) and DNA-synthesizing enzyme assays. Rats treated with Danazol for 14 days at 17-19 weeks of age showed a decrease of plasma gonadotropins associated with ovarian hypofunction, persistent diestrus, and a smaller number of corpora lutea in ovary, resulting in no BrdU-immunoreactive (S-phase) cells in endometrial epithelium and lower activity of thymidine kinase in the uterus compared with control.


Carcinogenesis | 1987

Relative activities of thymidylate synthetase and thymidine kinase in 1,2-dimethylhydrazine-induced colon carcinomas in rats

Shinobu Sakamoto; Kuwa K; Kunio Tsukada; Sagara T; Noriyuki Kasahara; Ryohei Okamoto


Anticancer Research | 1997

Additional effects of medroxyprogesterone acetate on mammary tumors in oophorectomized, estrogenized, DMBA-treated rats.

Sakamoto S; Hideki Kudo; Satoe Suzuki; Tadasu Mitamura; Shuji Sassa; Kuwa K; Chun Z; Yoshimura S; Maemura M; Tohru Nakayama; Shinoda H


Carcinogenesis | 1990

Thymidine kinase and α-fetoprotein as biochemical markers of hepatocarcinogenesis induced by 3′–methyl–4–dimethylaminoazobenzene treatment in rats

Shinobu Sakamoto; Hidematsu Hirai; Hiroko Taga; Toshiyuki Uchikoshi; Tatsuya Sunaga; Yasuo Endo; Kuwa K; Hideki Kudo; Yasuyuki Kawachi; Noriyuki Kasahara; Ryohei Okamoto


Anticancer Research | 1998

Effects of tamoxifen on mammary tumors and bone in 7,12-dimethylbenz-(a)anthracene-treated rats

Satoe Suzuki; Kitamura S; Sakamoto S; Shuji Sassa; Tadasu Mitamura; Hideki Kudo; Kuwa K; Yoshimura S; Maemura M; Tohru Nakayama; Zhou Yf; Hara Y; Shinoda H; Hiroshi Nagasawa


Planta Medica | 1993

Effects of Kampo (Japanese herbal) medicine Sho-Saiko-To on DNA-synthesizing enzyme activity in 1,2-dimethylhydrazine-induced colonic carcinomas in rats

Shinobu Sakamoto; Takao Mori; Sawaki K; Yasuyuki Kawachi; Kuwa K; Hideki Kudo; Satoe Suzuki; Yoshie Sugiura; Noriyuki Kasahara; Hiroshi Nagasawa


Oncology Reports | 1999

Correlation between histological differentiation and DNA-synthesizing enzymes in rat colorectal tumors induced with 1, 2-dimethylhydrazine.

Sakamoto S; Yasuyuki Kawachi; Takeo Iwama; Satoe Suzuki; Tadasu Mitamura; Shintarou Yoshimura; Kuwa K; Hideki Kudo; I Okayasu

Collaboration


Dive into the uwa K's collaboration.

Top Co-Authors

Avatar

Hideki Kudo

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Noriyuki Kasahara

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Satoe Suzuki

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Shinobu Sakamoto

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Sakamoto S

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Ryohei Okamoto

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Yasuyuki Kawachi

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Shuji Sassa

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Yoshie Sugiura

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge